5/19 Afrezza: What Is Possible Vs. What Is Probable •Afrezza scripts pass above 300 for the week ending May 12. •At annual meeting MannKind speaks to Afrezza without a prescription. •Cash remains critical issue with this company. https://seekingalpha.com/article/4074826-mannkind-afrezza-scripts-rise-management-offers-investors-new-carrot?auth_param=1vat:1chug6f:799d8319c7ec31623d8013845d4e89ab&uprof=51#alt3